• Catalog Number:

  E20-60073

• Amount:

  100ul

• Form of Antibody:

  Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. .

• Storage/Stability:

  Stability: -20°C/1 year

• class="eg_cn_title"Immunogen:

  The antiserum was produced against synthesized peptide derived from human CPI17 alpha around the phosphorylation site of Thr38. AA range5-54

• Purification:

  The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

• Reactivity:

  Human,Mouse,Rat

• Source:

  Rabbit

• Applications:

  WB: 1/500 - 1/2000. Immunohistochemistry: 1/100 - 1/300. ELISA: 1/20000. Not yet tested in other applications.

• Other Names:

  PPP1R14A; CPI17; PPP1INL; Protein phosphatase 1 regulatory subunit 14A; 17 kDa PKC-potentiated inhibitory protein of PP1; Protein kinase C-potentiated inhibitor protein of 17 kDa; CPI-17

• Specificity Sensitivity:

  Phospho-CPI-17 (T38) Polyclonal Antibody detects endogenous levels of CPI-17 protein only when phosphorylated at T38.

Enzyme-Linked Immunosorbent Assay (Phospho- ELISA) for Immunogen Phosphopeptide (Phospho- left) and Non-Phosphopeptide (Phospho-right), using CPI17 alpha (Phospho-Thr38) Antibody

Immunohistochemistry analysis of paraffin-embedded human breast carcinoma, using CPI17 alpha (Phospho- Thr38) Antibody. The picture on the right is blocked with the phospho peptide.